Early Access — free while we kick the tires
EdgarHawk

Lemaitre George W

Chairman and CEO

Director Officer

Latest: Chair selling · May 2026

6 filings analyzed · 1 company · Latest 2026-05-11

Companies

Company Buys Sells Direction
LEMAITRE VASCULAR INC LMAT 0 22 Net selling

Activity

May 2026
2026-05-11 LEMAITRE VASCULAR INC LMAT
medium
Sell
46,481 shares
$5,032,413
Significance 4/10

CEO George Lemaitre sold 46,481 shares for over $5M across two days as stock trades below 52-week highs.

George Lemaitre, Chairman and CEO, executed a pair of sales totaling over $5 million in company stock in early May. This represents a small reduction to his holdings—just 1.3% and 1.9% of shares across the two transactions—rather than a liquidation, but it's his 40th open-market sale in three years with zero offsetting open-market purchases. The stock is currently trading below its 52-week high despite posting strong fundamentals: the company is profitable with growing revenue, yet it's priced at a stretched multiple. Lemaitre's prior six sales at this stock have shown mixed timing results—roughly half the time the stock fell afterward (well-timed exits), and roughly half the time it rose (poorly-timed exits). This latest sale into a stock that has climbed sharply over the past three months but still sits below its peak could reflect either profit-taking or a cautious outlook; the historical mixed record suggests neither conviction nor consistent foresight guides his trading.

March 2026
2026-03-02 LEMAITRE VASCULAR INC LMAT
medium
Sell
205,930 shares
$22,043,375
Significance 6/10

Chairman/CEO LeMaitre George W sold 205,930 shares for $22,043,375.24 (two transactions, blended avg $107.04)

LeMaitre George W executed two separate open-market sales totaling 205,930 shares for $22,043,375.24 at an average price of $107.04, reducing his holdings by 12.2% from 1,682,430 shares to 1,476,500 shares. The company trades at a P/E of 36.53 with recent quarterly revenue of $61,046,000.00 and net income of $17,362,000.00, alongside 13.5% annual revenue growth. His cross-ticker track record shows a 90-day well-timed rate of 5.00% across 20 prior sells; at LMAT specifically, only 1 of 5 prior sales were well-timed at the 90-day mark, with most resulting in positive subsequent returns. The stock is currently up 26.4% over 30 days and 28.4% over 90 days, trading near its 52-week high range.

August 2025
2025-08-08 LEMAITRE VASCULAR INC LMAT
medium
Sell
100,000 shares
$9,350,530
Significance 5/10

Chairman/CEO George W LeMaitre sold 100,000 shares ($9.4M) at $93.51; holds 1.73M shares post-sale.

LeMaitre sold 100,000 shares (100.0K shares) at $93.51 on 2025-08-06, reducing his stake by -5.5% vs pre-transaction holdings of 1,827,003 shares (1.83M shares). The stock currently trades at $92.28, down -14.5% from its 52-week high of $107.97, though it is up +9.1% over 30 days and +15.0% over 90 days. His prior five trades at LMAT (May 2025) all occurred within a 4-day window and showed modest negative 30-day returns (-3.6% to -4.8%), suggesting a pattern of selling into strength or near local peaks. His broader cross-ticker track record shows 20 prior sells with a 0.00% well-timed rate at the 90-day mark (meaning his prior sells did not precede declines), indicating his sales have not historically preceded measurable downturns. The company reports strong fundamentals—$64.2M revenue in the latest quarter, $13.8M net income, +13.6% annual revenue growth, and a $2.1B market cap—providing no obvious distress signal that would explain a urgent exit.

May 2025
2025-05-20 LEMAITRE VASCULAR INC LMAT
high
Sell
100,000 shares
$8,556,631
Significance 6/10

LMAT CEO George W LeMaitre sold 100,000 shares for $8,556,631.41 across 5 transactions (May 16–20)

Chairman and CEO George W LeMaitre executed 5 separate sales totaling 100,000 shares (100.0K shares) for $8,556,631.41 (blended average $85.57) over four business days, reducing his holdings by 5.2% from 1,927,003 shares to 1,827,003 shares. The stock has declined 21.5% from its 52-week high of $107.97 and is down 17.8% over the past 90 days, trading at $84.75 versus the sale prices of $84.69–$85.86. Across his prior 5 sales at LMAT, the insider recorded a 0% well-timed rate (0 of 5 prior sells showed negative 90-day returns), and his cross-ticker track record shows a 0.00% well-timed rate on 20 prior sells, suggesting limited predictive success timing market reversals. Fundamentals show the company posted $11.0M net income on $59.9M revenue (latest quarter) with 13.6% annual revenue growth and a P/E of 42.38, but the magnitude and rapid sequence of these sales merit monitoring in context of recent price weakness.

July 2024
2024-07-18 LEMAITRE VASCULAR INC LMAT
medium
Sell
57,372 shares
$4,973,791
Significance 4/10

LMAT CEO LeMaitre sold 57,372 shares at $86.69 on 2024-07-16 for $4,973,790.96; maintains 1.90M shares post-transaction

LeMaitre George W, Chairman and CEO of LeMaitre Vascular, sold 57,372 shares at $86.69 on 2024-07-16, reducing his holdings to 1.90M shares (-2.9% of pre-transaction position). The sale occurred near the 52-week high of $87.02, with the stock at $85.31 currently and up 34.9% over 90 days. His cross-ticker track record shows 20 prior sells with a 0.00% well-timed rate at the 90-day mark and an average 90-day return of +16.2%, indicating his prior sales have generally preceded stock gains rather than declines. At this specific ticker, his 5 prior trades (all sells in May-July 2024) remain largely unmeasured for longer-term outcomes, with only the May trades showing modest 30-day gains of +2.9% to +3.3%. The company posted strong fundamentals with annual revenue growth of +19.7%, quarterly revenue of $53.5M, and quarterly net income of $9.9M, though the stock trades at a high P/E of 56.50.

2024-07-16 LEMAITRE VASCULAR INC LMAT
low
Sell
40,006 shares
$3,448,752
Significance 4/10

LMAT CEO George W LeMaitre sold 40,006 shares across 2 transactions for $3,448,752.15 in July 2024

George W LeMaitre, Chairman and CEO of LeMaitre Vascular, executed 2 separate sales totaling 40,006 shares for $3,448,752.15 on July 12 and July 15, 2024, at an average price of $86.21. The stock currently trades at $87.02, just 0.9% above the blended sale price, and the insider retains substantial holdings of 1,958,328 shares post-transaction. At the cross-ticker level, LeMaitre's prior open-market sells show a 90-day well-timed rate of 0.00%, indicating his sells historically have not preceded declines; at LMAT specifically, all 5 prior measurable sales (May and early July 2024) posted positive 30-day returns averaging 3.1%, and the 90-day outcomes remain incomplete. The company's fundamentals show strong revenue growth of 19.7% year-over-year and a P/E of 57.63 in a $2.0B market-cap position, with latest quarterly net income of $9,887,000. These sales represent a modest 2.0% reduction of his pre-transaction holdings and occur in a context where the stock has gained 8.6% over the past 30 days and 38.0% over 90 days, consistent with an insider liquidating a portion of an appreciated position.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access